Rua Life Sciences PLC Cash Flow-to-Debt Ratio
Rua Life Sciences PLC cash flow-to-debt ratio. Rua Life Sciences PLC (RUA) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of GBX29.00K could theoretically repay 0% of its total liabilities (GBX1.89 Million) in one year. Check RUA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Rua Life Sciences PLC (1994–2025)
Cash flow-to-debt ratio of Rua Life Sciences PLC from 1994 to 2025. Historical debt coverage capacity for Rua Life Sciences PLC across 33 annual periods. Check Rua Life Sciences PLC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Rua Life Sciences PLC Cash Flow-to-Debt Ratio by Year (1994–2025)
Rua Life Sciences PLC cash flow-to-debt ratio by year from 1994 to 2025. Year-by-year debt coverage analysis for Rua Life Sciences PLC. For the full cash flow conversion analysis, see RUA cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | GBX-137.00K | GBX1.89 Million | ▲ +38.3% |
| 2025 | -0.12x | GBX-219.00K | GBX1.86 Million | ▲ +91.3% |
| 2024 | -1.35x | GBX-1.33 Million | GBX987.00K | ▼ -12.3% |
| 2023 | -1.20x | GBX-1.17 Million | GBX980.00K | ▲ +47.1% |
| 2022 | -2.27x | GBX-2.36 Million | GBX1.04 Million | ▼ -162.6% |
| 2021 | -0.86x | GBX-1.42 Million | GBX1.65 Million | ▲ +56.2% |
| 2020 | -1.97x | GBX-431.00K | GBX219.00K | ▲ +54.6% |
| 2019 | -4.33x | GBX-429.00K | GBX99.00K | ▼ -183.7% |
| 2018 | 5.18x | GBX347.00K | GBX67.00K | ▲ +364.1% |
| 2017 | -1.96x | GBX-159.62K | GBX81.41K | ▼ -365.2% |
| 2016 | 0.74x | GBX84.70K | GBX114.56K | ▲ +164.2% |
| 2015 | -1.15x | GBX-189.82K | GBX164.91K | ▼ -1335.9% |
| 2014 | -0.08x | GBX-24.00K | GBX299.38K | ▼ -108.2% |
| 2013 | 0.97x | GBX346.19K | GBX355.41K | ▲ +646.8% |
| 2012 | 0.13x | GBX50.59K | GBX387.88K | ▲ +105.6% |
| 2011 | -2.31x | GBX-1.53 Million | GBX660.00K | ▲ +29.7% |
| 2010 | -3.29x | GBX-2.05 Million | GBX623.00K | ▼ -40.0% |
| 2009 | -2.35x | GBX-1.39 Million | GBX591.00K | ▼ -50.2% |
| 2008 | -1.56x | GBX-1.14 Million | GBX728.00K | ▼ -37.3% |
| 2007 | -1.14x | GBX-816.00K | GBX716.00K | ▲ +42.3% |
| 2006 | -1.98x | GBX-1.29 Million | GBX652.00K | ▲ +67.6% |
| 2005 | -6.09x | GBX-2.12 Million | GBX348.00K | ▼ -174.7% |
| 2004 | -2.22x | GBX-971.00K | GBX438.00K | ▲ +56.7% |
| 2003 | -5.12x | GBX-11.93 Million | GBX2.33 Million | ▼ -3.5% |
| 2002 | -4.94x | GBX-12.99 Million | GBX2.63 Million | ▼ -190.5% |
| 2001 | -1.70x | GBX-4.28 Million | GBX2.52 Million | ▼ -136.4% |
| 2000 | -0.72x | GBX-2.02 Million | GBX2.81 Million | ▲ +33.9% |
| 1999 | -1.09x | GBX-1.44 Million | GBX1.32 Million | ▼ -9.6% |
| 1998 | -0.99x | GBX-1.37 Million | GBX1.38 Million | ▼ -60.3% |
| 1997 | -0.62x | GBX-956.00K | GBX1.54 Million | ▼ -292.4% |
| 1996 | 0.32x | GBX446.00K | GBX1.39 Million | ▲ +362.4% |
| 1995 | -0.12x | GBX-233.00K | GBX1.90 Million | ▼ -495.8% |
| 1994 | -0.02x | GBX-36.00K | GBX1.75 Million | — |